Removing antimicrobial growth promoters and the rise of necrotic enteritis
For decades antibiotics have been extensively used in animal production worldwide 1 (see text box 1). Added in low doses to the feed of farm animals, they have been shown to increase daily weight gain and conversion of feed into body mass, leading to economic advantages for farmers 2, 3, 4, 5 . However, there is an increasing trend to reduce this use of antibiotics in feedstuffs. There are concerns that the use of antibiotics in the feed contributes to the spread of antibiotic resistance genes by promoting the selection of antibiotic resistant bacteria in animals. Also, waste materials from animals may contain antibiotic residues, resulting in their wider dissemination in the environment. Since January 1 st 2006, legislation has been in place in Europe to prohibit the use of antibiotics as growth promoters and in other continents the use of antimicrobial growth promoters in feedstuffs is under debate 6, 7, 8 .
The reduction in use of antibiotic growth promoters has had both expected and unexpected effects. The absence of antibiotic growth promoters is known to result in reduced feed conversion efficiencies 9 ; this has had economic consequences for livestock producers but is a manageable problem. More worryingly, some animal diseases have become more widespread -there are emerging diseases arising as a consequence of changes in farming practices. One of the most significant emerging diseases is necrotic enteritis (NE) of broiler chickens, which is caused by Clostridium perfringens. The full impact of the reduction in antibiotic growth promoters on the incidence of NE is not yet known because many countries are still implementing policies to reduce antibiotic usage in feedstuffs. However, insight into the extent of the problem can be gained from analyzing data from countries that had 4 abolished antibiotic growth promoters prior to the EU legislation. In Scandinavia the banning of antibiotic growth promoters was accompanied by a dramatic increase in the incidence of NE in poultry. For example, in Norway, most of the feed companies abolished antibacterial growth promoters in 1995 and within one month increases in the incidence of NE in flocks were evident, indicating that the AGPs had been an effective prophylactic treatment controlling NE. The problem was so great that alternative prescription antibiotics were introduced, although the total quantities of antibiotics used to treat NE were less than those used in feed 10, 11 . AGPs continue to be used in many of the major poultry producing regions, including North and South America and Asia. It has been estimated that NE costs the international poultry industry about 2 billion US dollars annually 12, 13 . The latest research into the biology of NE is precipitating a reassessment of our understanding of the disease process and is offering new avenues for the development of vaccines to address this important economic issue.
Necrotic enteritis in broiler chickens
C. perfringens produces several myonecrotic and gastrointestinal diseases in humans, domesticated livestock and in birds 14, 15 . As a species C. perfringens is capable of producing a wide range of toxins (see Text box 2), but individual strains produce only a sub-set of these toxins. The differential production of the four so-called major toxins (α-, β-, ε-and ι-toxin) is used to classify strains into five toxinotypes (A, B, C, D and E) 16 . In poultry, both clinical and subclinical NE are typically caused by C. perfringens type A
17
. Of the major typing toxins, type
A strains produce only α-toxin, which is responsible for the ability of C. perfringens strains to cause gas gangrene 18 .
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Since spores of C. perfringens type A are ubiquitous in the environment and are ingested continuously via poultry feed, it is generally accepted that predisposing factors are required for these bacteria to cause disease. Complex interactions between members of the gut flora play a role in establishing NE. The best known predisposing factor is pre-existing mucosal damage caused by coccidiosis 19, 20, 21 . Coccidiosis is caused by Eimeria parasites that colonize the gut and kill epithelial cells as a consequence of the intracellular stages of their life cycle.
The resulting gaps in the epithelial lining of the intestinal lumen may trigger rapid replication and/or toxin production by certain C. perfringens strains.
Necrotic enteritis is characterised clinically by a sudden increase in flock mortality, often without premonitory signs although wet litter is sometimes an early indicator of disease. At necropsy large necrotic foci are found in the small intestinal mucosa (Fig 1a) and in severe cases the whole mucosal surface of the gut is affected, with extensive necrosis of the lumen surface (Fig 1b) . The typical form of the disease leads to increased mortality in broiler flocks during the last weeks of the rearing period 20 . In the past few years, for reasons that are not clear, C. perfringens has been associated with a form of NE with clinical signs that are milder than the classical acute form of NE 22, 23, 24 . In this subclinical form, C. perfringens causes chronic damage to the intestinal mucosa, which leads to decreased digestion and absorption, reduced weight gain and increased feed conversion ratio 25, 26 It is this manifestation of the disease that reportedly causes the greatest economic losses in the poultry production industry 27 .
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Histopathology of NE lesions
Early microscopic studies of NE lesions described clearly demarcated foci of advanced tissue degeneration with villi partially or fully denuded of epithelium, large sheets of disintegrating cells found in the lumen and congestion of blood vessels in the lamina propria and submucosa 28, 29 . 
Do Clostridium perfringens toxins play a role in NE?
For more than 20 years, α-toxin has been proposed to be the main virulence factor for NE in poultry. The origin of this assumption is unclear, but seems to lie in the observations that crude supernatant from C. perfringens type A cultures induced necrotic lesions in broilers 32 and that serum containing antibodies to C. perfringens α-toxin prevented the development of lesions 33 . Maternal vaccination with a crude C. perfringens type A and C toxoid has been 7 shown to induce antibodies against α-toxin in chicks, which were partially protected against NE 34 . The interpretation of these early studies is unclear because they used crude supernatant and the assumption was made that the effects were caused by the dominant protein present, i.e. α-toxin. However, many other proteins are also present in the supernatant of C. perfringens cultures. More recently, other epidemiological and experimental evidence has supported the proposal that α-toxin is an important protective antigen. Two independent studies have shown that poultry that are immune to NE have high titres of antibodies to α-toxin 35, 36 . Recently, more convincing evidence of the possible involvement of α-toxin has come from immunization with purified α-toxoid, which induced protection against experimentally induced NE
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Against this background, other recent studies have clearly indicated that α-toxin plays no direct role in the pathogenesis of NE. C. perfringens isolates associated with NE and isolates derived from the microbiota of normal broilers are predominantly type A
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. There is no apparent difference in the levels of α-toxin production in vitro by normal microbiota and outbreak isolates 38 . In fowl models of NE the disease can be reproduced by type A strains from outbreaks of NE but not by other type A strains, even though both groups of isolates produce α-toxin
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. However, the most convincing evidence of the lack of involvement of α-toxin in disease comes from studies using an α-toxin negative mutant of a C. perfringens strain from an NE outbreak. In virulence trials both the wild-type strain and an isogenic α-toxin negative mutant were able to cause NE lesions in chickens 39 . In contrast, in another study spontaneously derived α-toxin mutants of a virulent strain clearly had an impaired ability to cause NE lesions 40 . However, these mutants were not complemented with a functional α-toxin 8 gene so it was not clear that the reduced virulence was due to the impairment of α-toxin production.
Other observations also argue strongly against a role for α-toxin in NE. The massive inflammation caused by granulocytes transmigrating from the tissue into the lumen is a hallmark of broiler NE 38, 41 . It is markedly different to the leukostasis and lack of inflammation induced by α-toxin in gas gangrene 42 . Indeed, α-toxin negative mutants of C. perfringens do promote profound inflammatory responses and are unable to cause gas gangrene in mice 18 .
Thus the massive immune cell influx in NE lesions seems to be inconsistent with the known effects of α-toxin on the innate immune system 38, 41 . Further, histological analysis of tissue damage occurring in early stages of lesion development is not consistent with the phospholipase C or sphingomyelinase activities of α-toxin
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With evidence mounting that α-toxin did not play a major role in the pathogenesis of NE there was a need to reevaluate previous work and an opportunity to search for other factors important in pathogenesis. The earlier evidence used to suggest a role for α-toxin is still valuable because it did indicate that there are molecules in C. perfringens culture supernatant that when infused into gut reproduced disease-like pathology 32 . This result showed that significant virulence factors must be present in the secreted cell products.
NetB, the new toxin on the block
Recently, NetB, a novel toxin that is associated with broiler NE has been described 43 . The toxin was identified using screens for proteins from the supernatant of C. perfringens cultures 9 that were cytotoxic for chicken hepatocellular carcinoma cells (LMH) in vitro. The netB structural gene was identified by genomic sequencing of an NE isolate 43 . Both native and recombinant NetB were shown to be cytotoxic for LMH cells and the mechanism of action appears to involve the formation of small hydrophilic 1.6 -1.8 nm pores 43 . A netB mutant of C.
perfringens was unable to cause necrotic lesions in the gut of experimentally infected broilers, but a complemented netB mutant was virulent, like the wild-type strain 43 . Additional evidence for the role of NetB in disease comes from the finding that most NE outbreak strains carry the netB gene, whilst C. perfringens isolates from other diseases of animals lack this gene and therefore do not produce NetB toxin. This finding has been confirmed and extended by the authors of this review for isolates from Denmark and Belgium, where eight out of eleven isolates from diseased chickens carried the netB gene, compared to one out of thirty-two isolates from healthy broilers. However, this story may yet have some further twists to the tail.
It is unclear whether the occasional NE isolates that lack the netB gene posses a sequence divergent from that of the published toxin or whether other as yet unidentified toxins can confer disease-causing potential on C. perfringens isolates. A further complication is that not all strains isolated from diseased birds are necessarily still pathogenic, for instance Thompson et al. (2006) 40 found that two of the six isolates they tested were not pathogenic.
Hence, caution is required when interpreting surveys of isolates from disease outbreaks;
isolates may change during the culturing process or there may even be a mixture of pathogenic and non-pathogenic stains present in some diseased birds.
It is possible that other virulence factors, such as hydrolytic enzymes and other (unidentified)
toxins also play a role in the complex pathogenesis of the disease. For example, it has been suggested that in the initial stages of NE proteolytic enzymes play an important role, causing disruption of the basal lamina matrix and the lateral domain of enterocytes 30 . Indeed, in broilers undergoing NE, the extracellular matrix is disorganized and can even be completely absent.
Vaccination with α-toxin
Until recently, most vaccination efforts directed against NE have concentrated on the use of culture supernatant toxoids in which α-toxin was the major component 34, 44, 45 . These trials have been of limited success. More recently, vaccines using recombinant α-toxin and live delivery of α-toxin by attenuated Salmonella have been evaluated and shown to give partial protection against NE in experimental challenge models 31, 46, 47 . With evidence accumulating that α-toxin may not play an important role in NE pathogenesis the question arises as to how antibodies to the protein can offer any level of protection. α-toxin is the major protein found in C. perfringens culture supernatants and so it was always regarded solely as a secreted protein.
As such it was difficult to see how antibodies to the protein could affect disease outcomes if α-toxin was not an important factor in pathogenesis.
Insight into the role in protection of antibodies to α-toxin comes from a recent study by 47 . These researchers found that serum from broilers that had been vaccinated with a Salmonella enterica subspecies Typhimurium ∆asd pabA pabB mutant secreting the C-terminal (non-toxic) domain of α-toxin bound to the cell surface of C.
perfringens and suppressed its growth in broth cultures. This result clearly shows that although α-toxin is primarily secreted some toxin must also be retained on the cell surface. . Two of these proteins, fructose-biphosphate-aldolase, and a hypothetical protein (possibly a metallopeptidase) also gave some protection when delivered by a live Salmonella vector 48 .
Other proteins that have been shown to play a role in pathogenesis will be well worth testing as vaccine antigens. These include the NetB protein identified by Keyburn et al. (2008) 43 and the metalloproteinases that are suggested to have a key role in early lesion development 30 .
Conclusion
The story of NE in intensively reared poultry is fascinating and highlights some of the pitfalls in both policy and in research. The abolition of growth promoters in feedstuffs was initially accompanied by significant increases in disease in animals. In part, this change in the pattern of disease reflects the ways in which farming practices have become interdependent and the difficulties associated with isolated changes in these practices. The story of NE also highlights the dangers of making scientific assumptions and the ease with which such assumptions can become embedded in the literature as fact. However, the story is not one only of pitfalls and problems. The research carried out over the past few years is creating a paradigm shift in our understanding of the pathogenesis of this disease and is now providing the essential information that will be required to monitor and control the incidence of NE in poultry. As new tools, such as relatively cheap whole genome sequencing, targeted mutation and improved disease models are developed we are better able to investigate issues such as the complex etiology of this multifactorial disease. We can look forward to major advances in our . The ability of C.
perfringens to cause disease is ascribed mainly to the differential production of four major and 10 minor protein toxins 15, 55 . The roles of some of these toxins in disease is well understood. For example, α-toxin, which is produced by all five toxinotypes, is the main virulence determinant in gas gangrene and mutated strains that are unable to produce α-toxin are unable to cause disease in mice 18, 54 . The ε-and β-toxins appear to 
